Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
European Urology Open Science|November 26, 2021
Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Laura Villier, et al.European Urology Focus|June 20, 2021
Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Maëlle Verardo, et al.Scientific Reports|March 3, 2016
Innate myeloid cell TNFR1 mediates first line defence against primary Mycobacterium tuberculosis infectionNoria Segueni, Sulayman Benmerzoug, Stéphanie Rose, et al.European Urology Open Science|October 10, 2022
Intravesical Ty21a Treatment of Non-muscle-invasive Bladder Cancer Shows a Good Safety ProfileIlaria Lucca, Laurent Derré, Valérie Cesson, et al.Journal for Immunotherapy of Cancer|December 15, 2023
Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potentialLaurent Derré, Ilaria Lucca, Valérie Cesson, et al.Nature Communications|December 8, 2018
STING-dependent sensing of self-DNA drives silica-induced lung inflammationSulayman Benmerzoug, Stéphanie Rose, Badreddine Bounab, et al.Pageof 2